Sort
21,453 grants matching “tuberculosis”
HPMI: Host Pathogen Mapping Initiative
$2,000,000Nevan J Krogan · University Of California, San Francisco · U19 · FY2018 · AI
HPMI: Host Pathogen Mapping Initiative
$2,000,000Nevan J Krogan · University Of California, San Francisco · U19 · FY2021 · AI
International TB Portals Program
$2,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
TUBERCULOSIS VACCINE DEVELOPMENT
$2,000,000Christopher Case · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
Advancing Vaccine Adjuvant Research for Tuberculosis (TB)
$2,000,000Warwick Britton · University Of Sydney · N01 · FY2025 · AI
Regional Prospective Observational Research in Tuberculosis (RePORT) India Consortium (RePORT-India)
$2,000,000Michael Dignam · National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
International Biomedical Research Projects
$2,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2013 · AI
PHASE I CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES
$2,000,000John McLeod Griffiss · Icon Government And Public Health Solutions, Inc. · N01 · FY2011 · AI
COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
$2,000,000University Of Kwazulu-Natal · U19 · FY2004 · AI
Genomic Sequencing Center for Infectious Diseases
$2,000,000Bruce Birren · Broad Institute, Inc. · N01 · FY2013 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,999,995Joshua D Jones · Chicago Department Of Public Health · U52 · FY2009 · PS
WADSWORTH CTR: INFECTIOUS DIS, WEST NILE, AIDS, MALARIA, TB, BIOTERRORISM, LYME
$1,999,323Wadsworth Center · C06 · FY2002 · RR
The Asia-Pacific HIV Research Collaboration
$1,999,016David A Cooper · Foundation For Aids Research · U01 · FY2015 · AI
Immune modulation by highly virulent clinical isolates of M.tuberculosis
$1,998,452Diane Joyce Ordway · Colorado State University · DP2 · FY2009 · OD
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit
$1,995,627Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2014 · AI
IeDEA Asia-Pacific Research Collaboration
$1,994,336Annette H Sohn · Foundation For Aids Research · U01 · FY2017 · AI
Bronchiectasis and chronic airway infection
$1,994,105Kenneth Olivier · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
GHESKIO Clinical Trials Unit
$1,993,512Jean William Pape · Gheskio Center · UM1 · FY2023 · AI
ADULT AIDS CLINICAL TRIALS UNIT (AACTU)
$1,992,814University Of Rochester · U01 · FY2004 · AI
Omics for TB: Response to Infection and Treatment
$1,991,315Alan A Aderem · Seattle Children'S Hospital · U19 · FY2018 · AI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,990,761Thomas A Waldmann · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
CENTER FOR AIDS RESEARCH(CFAR)
$1,990,746Michael Marcel Lederman · Case Western Reserve University · P30 · FY2006 · AI
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis
$1,989,733Aaron Esser-Kahn · University Of Chicago · N01 · FY2024 · AI
Optimizing Combination Therapy to Accelerate Clinical Cure of Tuberculosis
$1,988,816George Louis Drusano · University Of Florida · P01 · FY2017 · AI
East Africa IeDEA Regional Consortium
$1,987,780Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2011 · AI